# Research progress on DNA hydroxymethylation in atrial fibrillation: a review

## TL;DR

This review explores how DNA hydroxymethylation might influence the development and progression of atrial fibrillation, a common heart condition.

## Contribution

The paper provides a comprehensive review of DNA hydroxymethylation's potential role in atrial fibrillation, an area that remains underexplored.

## Key findings

- DNA hydroxymethylation is increasingly recognized in various diseases but is less studied in atrial fibrillation.
- The review highlights possible mechanisms linking DNA hydroxymethylation to atrial fibrillation progression.
- Current evidence suggests a need for further research to clarify the role of this epigenetic modification in atrial fibrillation.

## Abstract

Epigenetic modifications play a critical role in the pathogenesis and progression of cardiovascular diseases. Among these, DNA hydroxymethylation has garnered increasing attention in the fields of oncology, hematology, and neurological disorders, serving as a key mechanism for untangling molecular pathways underlying disease etiology. Although emerging evidence has begun to illuminate the role of DNA hydroxymethylation in cardiovascular conditions such as coronary artery disease and atherosclerosis, its implications in atrial fibrillation remain underexplored. This review aims to summarize current understanding and discuss potential mechanisms through which DNA hydroxymethylation may contribute to the development and progression of atrial fibrillation.